TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
HELP

Cybin Inc.

Healthcare · Biotechnology

11.40$ -2.4% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Balance Sheet

Cybin Inc. (HELP) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 259 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet HELP
Line item Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q4 19 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
0.3 0.5 – 0.5 – 0.4 – – – 8.9 5.8 61 92 83 105 95 84 75 69 61 54 46 58 130 302 285 262 254 180 155 253 290 350 259
0.3 0.5 – 0.4 – 0.4 – – – 8.8 5.7 43 66 58 79 69 58 48 38 30 23 16 27 49 219 201 179 168 115 105 160 223 257 192
0.3 0.5 – 0.4 – 0.4 – – – 7.7 0.2 40 64 55 75 64 54 42 30 23 17 9.3 18 39 209 183 154 136 94 87 117 195 219 166
0.3 0.5 – 0.4 – 0.4 – – – 7.7 0.2 40 64 55 75 64 54 43 30 23 17 9.3 18 39 209 183 154 136 – 87 117 195 219 166
– – – – – – – – – 0.4 0.6 1.2 1.3 1.7 2.3 2.2 2.1 2.3 2.8 2.6 3.1 3.2 3.7 4.3 4.5 4.6 5.5 5.6 4.1 3.0 6.6 4.8 7.0 5.0
– – – – – – – – – 0.6 0.5 0.3 – – – – 1.3 1.3 3.2 2.9 1.7 1.3 3.1 – 2.9 – – – – – – – – –
– – – – – – – – – – – – 23 23 23 23 23 24 25 25 25 24 25 36 47 48 47 49 36 27 51 37 51 36
– – – – – – – – – – – 18 1.7 1.8 1.9 2.0 2.1 2.2 5.1 5.3 5.5 5.4 5.8 44 35 36 36 37 29 22 42 30 42 31
0.0 0.0 – 0.0 – 0.0 – – – 2.3 1.1 8.4 6.0 6.6 6.1 6.1 7.9 6.4 4.9 4.4 5.7 6.0 9.2 8.5 10 4.8 7.4 13 15 43 59 16 27 18
0.0 0.0 – 0.0 – 0.0 – – – 2.3 1.1 4.9 4.9 5.8 5.7 6.1 7.9 6.4 4.9 4.4 5.7 6.0 9.2 8.5 10 4.8 7.4 13 15 11 19 16 27 18
– – – – – – – – – – – 0.0 – – – – – – – – – – – 0.3 0.3 0.2 0.1 – – – – – – –
– – – – – – – – – 1.3 1.1 1.8 2.8 3.1 2.6 3.0 5.3 5.9 4.9 4.4 5.7 6.0 9.2 8.1 9.8 4.6 7.2 13 21 21 19 22 – –
– – – – – – – – – – – – – – – – – – – – – – – – – – – – – 45 29 – – –
0.3 0.5 – 0.4 – 0.4 – – – 6.6 4.7 53 86 76 99 89 76 68 64 56 48 40 48 121 292 280 255 240 165 111 194 274 323 242
-0.1 -0.3 – -0.3 – -0.4 – – – -5.2 -7.8 -19 -33 -48 -65 -83 -101 -114 -124 -134 -148 -163 -175 -205 -226 -241 -298 -309 -255 -195 -418 -342 -543 -437
0.4 0.3 0.4 0.4 0.4 0.4 0.4 0.4 1.3 1.6 1.6 2.9 4.0 4.2 4.4 4.5 4.6 4.6 4.8 5.0 5.2 5.4 6.2 8.8 20 20 20 20 22 22 24 24 50 52

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?